Trial reportOrthopadie (Heidelberg, Germany)2026
[Effectiveness of digital therapy in patellofemoral pain treatment].
Trial report in Orthopadie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatellar pathologies are a common manifestation of musculoskeletal disorders. Digital health applications (DiGA), such as Mawendo, offer an alternative therapeutic approach to physiotherapy. AIM OF THE STUDY: This study aimed to evaluate the effectiveness of the DiGA-Mawendo compared to conventional physiotherapy in patients with patellofemoral pain, based on the KOOS subscales.
methodsA total of 253 participants were randomly assigned to either a DiGA or physiotherapy group over a period of 12 weeks. The primary endpoints were the KOOS subscales, which were analyzed descriptively and using ANCOVA models.
resultsDiGA-Mawendo showed significantly better outcomes in all subscales, exceeding the minimum clinically important difference (MCID) in each case. DISCUSSION: DiGA demonstrated a clinically relevant, multidimensional therapeutic effect across all subscales. Its flexible use and high effectiveness support its complementary role in healthcare delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.